日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Synechococcus sp. Biosynthetic arginine decarboxylase (speA), partial CSB-YP401236SVB
CSB-EP401236SVB
CSB-BP401236SVB
CSB-MP401236SVB
CSB-EP401236SVB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. DNA ligase (ligA), partial CSB-YP401237SVB
CSB-EP401237SVB
CSB-BP401237SVB
CSB-MP401237SVB
CSB-EP401237SVB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lachancea kluyveri Urea amidolyase (DUR1,2), partial CSB-YP401238LMA
CSB-EP401238LMA
CSB-BP401238LMA
CSB-MP401238LMA
CSB-EP401238LMA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant WU polyomavirus Large T antigen, partial CSB-YP401239WBG
CSB-EP401239WBG
CSB-BP401239WBG
CSB-MP401239WBG
CSB-EP401239WBG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Chromosomal replication initiator protein DnaA (dnaA) CSB-YP401240CWV
CSB-EP401240CWV
CSB-BP401240CWV
CSB-MP401240CWV
CSB-EP401240CWV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum UPF0133 protein CBO0032/CLC_0052 (CBO0032, CLC_0052) CSB-YP401241CWV
CSB-EP401241CWV
CSB-BP401241CWV
CSB-MP401241CWV
CSB-EP401241CWV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum S-adenosylmethionine synthase (metK) CSB-YP401242CWV
CSB-EP401242CWV
CSB-BP401242CWV
CSB-MP401242CWV
CSB-EP401242CWV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum UPF0059 membrane protein CBO0394 (CBO0394), partial CSB-YP401243CWV1
CSB-EP401243CWV1
CSB-BP401243CWV1
CSB-MP401243CWV1
CSB-EP401243CWV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum UPF0316 protein CBO0591/CLC_0646 (CBO0591, CLC_0646), partial CSB-YP401244CWV1
CSB-EP401244CWV1
CSB-BP401244CWV1
CSB-MP401244CWV1
CSB-EP401244CWV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Putative cobalt-precorrin-6A synthase [deacetylating] (cbiD) CSB-YP401245CWV
CSB-EP401245CWV
CSB-BP401245CWV
CSB-MP401245CWV
CSB-EP401245CWV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Bifunctional protein FolD (folD) CSB-YP401246CWV
CSB-EP401246CWV
CSB-BP401246CWV
CSB-MP401246CWV
CSB-EP401246CWV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Cell division protein SepF (sepF) CSB-YP401247CWV
CSB-EP401247CWV
CSB-BP401247CWV
CSB-MP401247CWV
CSB-EP401247CWV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum (Dimethylallyl)adenosine tRNA methylthiotransferase MiaB CSB-YP401248CWV
CSB-EP401248CWV
CSB-BP401248CWV
CSB-MP401248CWV
CSB-EP401248CWV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Exodeoxyribonuclease 7 small subunit (xseB) CSB-YP401249CWV
CSB-EP401249CWV
CSB-BP401249CWV
CSB-MP401249CWV
CSB-EP401249CWV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum UPF0597 protein CBO2008/CLC_1955 (CBO2008, CLC_1955) CSB-YP401250CWV
CSB-EP401250CWV
CSB-BP401250CWV
CSB-MP401250CWV
CSB-EP401250CWV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Ribosomal protein S12 methylthiotransferase RimO (rimO) CSB-YP401251CWV
CSB-EP401251CWV
CSB-BP401251CWV
CSB-MP401251CWV
CSB-EP401251CWV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Ribonuclease HII (rnhB) CSB-YP401252CWV
CSB-EP401252CWV
CSB-BP401252CWV
CSB-MP401252CWV
CSB-EP401252CWV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Phosphopantetheine adenylyltransferase (coaD) CSB-YP401253CWV
CSB-EP401253CWV
CSB-BP401253CWV
CSB-MP401253CWV
CSB-EP401253CWV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Shikimate dehydrogenase (aroE) CSB-YP401254CWV
CSB-EP401254CWV
CSB-BP401254CWV
CSB-MP401254CWV
CSB-EP401254CWV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum V-type ATP synthase alpha chain (atpA), partial CSB-YP401255CWV
CSB-EP401255CWV
CSB-BP401255CWV
CSB-MP401255CWV
CSB-EP401255CWV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×